TAMMY PUGH: Open Payments
NPI 1487672465 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 20 payments from 14 companies in 2025. Trend: 2023 $38 · 2024 $117 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $76 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Genmab U.S., Inc. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $35 |
| GENZYME CORPORATION | 1 | $28 |
| Incyte Corporation | 1 | $22 |
| Stemline Therapeutics Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: KEYTRUDA, Enhertu, Epkinly, DATROWAY, SARCLISA, REBLOZYL, JAKAFI, DARZALEX.
Industry payments across AL — which companies pay providers there.
